Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Subscriber Content

Oculus Announces SFDA Approval of Wound Healing Product

publication date: Jul 12, 2012

Oculus Innovative Sciences of California received SFDA approval for Microcyn® Hydrogel, a topical treatment for moistening, repairing and healing of acute and chronic wounds. With the approval in hand, Shanghai Sunvic, the China partner of Oculus, will launch the product in Q3 of 2012, marketing Microcyn Hydrogel in both the OTC and professional healthcare markets in China. More details....

Stock Symbol: (NSDQ: OCLS)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.If you're not a subscriber why not subscribe today?